Sign Up Today and Learn More About Endeavor BioMedicines Stock
Invest in or calculate the value of your shares in Endeavor BioMedicines or other pre-IPO companies through EquityZen's platform.
Endeavor BioMedicines Stock (ENBI)
Endeavor BioMedicines develops new treatments targeting the underlying causes of pulmonary fibrosis.
About Endeavor BioMedicines Stock
Founded
2018
Headquarters
Solana Beach, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Endeavor BioMedicines Press Mentions
Stay in the know about the latest news on Endeavor BioMedicines
Idiopathic pulmonary fibrosis: Refoxy, Boehringer, Insilico, and more on the hunt for curative treatments
labiotech • Dec 05, 2024
Endeavor BioMedicines to Present New Data From Phase 2a Clinical Trial of ENV-101 at American Thoracic Society 2024 International Conference
businesswire • Aug 04, 2024
New Phase 2a Clinical Trial Results Demonstrate Endeavor BioMedicines' ENV-101 Improved Lung Function and ...
businesswire • Jul 05, 2024
Taking on pharma giants, Endeavor links IPF drug to improved lung function in phase 2
fiercebiotech • Jun 04, 2024
Endeavor Raises $132M in Oversubscribed Series C to Advance Lung Disease, ADC Candidates
biospace • Jun 04, 2024
Endeavor BioMedicines Management
Leadership team at Endeavor BioMedicines
Founder and Executive Chairman
John Hood
Co-Founder and Chief Scientific Officer
Miguel de los Rios
Join now and verify your accreditation status to gain access to:
- Endeavor BioMedicines current valuation
- Endeavor BioMedicines stock price
- Available deals in Endeavor BioMedicines and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Endeavor BioMedicines Stock
How to invest in Endeavor BioMedicines stock?
Accredited investors can buy pre-IPO stock in companies like Endeavor BioMedicines through EquityZen funds. These investments are made available by existing Endeavor BioMedicines shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Endeavor BioMedicines stock?
Shareholders can sell their Endeavor BioMedicines stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
